$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

$nhi Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000087786024000080 Filed on November 05, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$82.94M
YoY Change		3.54%
Cost Of Revenue		$13.53M
YoY Change		4.48%
Gross Profit		$69.41M
YoY Change		3.37%
Gross Profit Margin		83.69%
Selling, General & Admin		$5.133M
YoY Change		14.07%
% of Gross Profit		7.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$17.77M
YoY Change		1.44%
% of Gross Profit		25.6%
Operating Expenses		$54.80M
YoY Change		5.37%
Operating Profit		$14.61M
YoY Change		-3.49%
Interest Expense		$14.94M
YoY Change		-0.97%
% of Operating Profit		102.25%
Other Income/Expense, Net		$0.00
YoY Change		-100.0%
Pretax Income		$28.24M
YoY Change		-2.71%
Income Tax
% Of Pretax Income
Net Earnings		$28.54M
YoY Change		-2.75%
Net Earnings / Revenue		34.41%
Basic Earnings Per Share		$0.66
Diluted Earnings Per Share		$0.65
COMMON SHARES
Basic Shares Outstanding	45.42M shares	43.44M shares
Diluted Shares Outstanding		43.99M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$15.55M
YoY Change		-6.33%
Cash & Equivalents	$24.29M	$15.55M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables		$6.237M
Other Receivables		$86.33M
Total Short-Term Assets		$108.1M
YoY Change		3.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.211B	$2.097B
YoY Change	4.94%	-1.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$7.886M
YoY Change		-38.39%
Total Long-Term Assets		$2.352B
YoY Change		-1.78%
TOTAL ASSETS
Total Short-Term Assets		$108.1M
Total Long-Term Assets		$2.352B
Total Assets	$2.614B	$2.460B
YoY Change	5.06%	-1.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$32.51M
YoY Change		10.95%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$71.77M
YoY Change		4.92%
LONG-TERM LIABILITIES
Long-Term Debt		$1.136B
YoY Change		-0.71%
Other Long-Term Liabilities		$4.612M
YoY Change		-14.59%
Total Long-Term Liabilities		$1.141B
YoY Change		-0.77%
TOTAL LIABILITIES
Total Short-Term Liabilities		$71.77M
Total Long-Term Liabilities		$1.141B
Total Liabilities	$1.229B	$1.213B
YoY Change	1.22%	-0.46%
SHAREHOLDERS EQUITY
Retained Earnings	$2.605B	$2.562B
YoY Change	5.59%	5.21%
Common Stock	$1.737B	$1.602B
YoY Change	8.3%	-0.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.366B	$1.229B
YoY Change
Total Liabilities & Shareholders Equity	$2.614B	$2.460B
YoY Change	5.06%	-1.56%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$28.54M
YoY Change		-2.75%
Depreciation, Depletion And Amortization		$17.77M
YoY Change		1.44%
Cash From Operating Activities		$48.63M
YoY Change		-2.15%
INVESTING ACTIVITIES
Capital Expenditures		$2.027M
YoY Change		-22.04%
Acquisitions
YoY Change
Other Investing Activities		$455.0K
YoY Change		-102.61%
Cash From Investing Activities		-$1.572M
YoY Change		-92.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-46.19M
YoY Change		51.45%
NET CHANGE
Cash From Operating Activities		48.63M
Cash From Investing Activities		-1.572M
Cash From Financing Activities		-46.19M
Net Change In Cash		864.0K
YoY Change		-208.0%
FREE CASH FLOW
Cash From Operating Activities		$48.63M
Capital Expenditures		$2.027M
Free Cash Flow		$46.60M
YoY Change		-1.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	5913000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2820430000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2780358000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	723606000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	673276000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2096824000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2107082000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19411000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15476000	usd
CY2024Q3	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	232550000	usd
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	245271000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15550000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22347000	usd
CY2024Q3	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	86334000	usd
CY2023Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	84713000	usd
CY2024Q3	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	5669000	usd
CY2023Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	5004000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	23163000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	24063000	usd
CY2024Q3	us-gaap	Assets Assets	2460090000	usd
CY2023Q4	us-gaap	Assets Assets	2488480000	usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1136302000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1135051000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	32508000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	34304000	usd
CY2024Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	39260000	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	39069000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	6009000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	1212682000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1214433000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	8925000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1603757000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2561587000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2466844000	usd
CY2024Q3	us-gaap	Cumulative Dividends CumulativeDividends	2934523000	usd
CY2023Q4	us-gaap	Cumulative Dividends CumulativeDividends	2817083000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	1228950000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1253952000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	9533000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	10439000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1238483000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1264391000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2460090000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2488480000	usd
CY2023Q4	nhi	Number Of Real Estate Partnerships NumberOfRealEstatePartnerships	2	realestatepartnership
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	2270000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	2225000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24617000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21516000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	2217000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	1916000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17767000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18495000	usd
CY2024Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
CY2022Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
CY2023Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3512000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3740000	usd
CY2024Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2300000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	28242000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	29033000	usd
	us-gaap	Net Income Loss NetIncomeLoss	94743000	usd
	us-gaap	Net Income Loss NetIncomeLoss	103608000	usd
CY2024Q3	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	29000	usd
CY2023Q3	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	19000	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	90000	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	38000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28511000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29327000	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Address City Or Town EntityAddressCityOrTown	Murfreesboro
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45422064	shares
CY2024Q3	us-gaap	Land Land	181173000	usd
CY2023Q4	us-gaap	Land Land	180749000	usd
CY2024Q3	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2627928000	usd
CY2023Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	2593696000	usd
CY2024Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	11329000	usd
CY2024Q3	us-gaap	Deferred Revenue DeferredRevenue	4612000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	9656000	usd
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43622064	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43409841	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	436000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	434000	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1601450000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	nhi	Payment Of Tenant Lease Incentives PaymentOfTenantLeaseIncentives	0	usd
	nhi	Payment Of Tenant Lease Incentives PaymentOfTenantLeaseIncentives	10000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-120302000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6850000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3021000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24617000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21516000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17767000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18495000	usd
	us-gaap	Interest Paid Net InterestPaidNet	45250000	usd
	us-gaap	Interest Paid Net InterestPaidNet	41222000	usd
	us-gaap	Notes Issued1 NotesIssued1	0	usd
	us-gaap	Depreciation Depreciation	52763000	usd
	us-gaap	Depreciation Depreciation	52862000	usd
CY2024Q3	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	10744000	usd
CY2023Q3	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	67000	usd
CY2024Q3	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	83000	usd
	dei	Local Phone Number LocalPhoneNumber	890-9100
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43622064	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43409841	shares
CY2024Q3	us-gaap	Lease Income LeaseIncome	63318000	usd
CY2023Q3	us-gaap	Lease Income LeaseIncome	62255000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
	us-gaap	Lease Income LeaseIncome	191265000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35860000	usd
CY2024Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5855000	usd
CY2023Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5484000	usd
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	17745000	usd
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	16005000	usd
CY2024Q3	us-gaap	Revenues Revenues	82944000	usd
	us-gaap	Revenues Revenues	249426000	usd
	us-gaap	Revenues Revenues	240370000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	17768000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	17515000	usd
CY2024Q3	us-gaap	Interest Expense Operating InterestExpenseOperating	14939000	usd
CY2023Q3	us-gaap	Interest Expense Operating InterestExpenseOperating	15086000	usd
	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	29525000	usd
	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	641000	usd
	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	364000	usd
CY2023Q3	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	2000	usd
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	-56000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4810000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4430000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15318000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14390000	usd
CY2024Q3	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	2786000	usd
CY2023Q3	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	2908000	usd
	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	8738000	usd
CY2024Q3	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	3434000	usd
CY2023Q3	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1959000	usd
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	4550000	usd
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1727000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	54804000	usd
CY2024Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2023Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	20000	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000	usd
CY2024Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000877860
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	National Health Investors, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	62-1470956
	dei	Entity Address Address Line1 EntityAddressAddressLine1	222 Robert Rose Drive
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37129
	dei	City Area Code CityAreaCode	(615)
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	NHI
	dei	Security Exchange Name SecurityExchangeName	NYSE
	us-gaap	Lease Income LeaseIncome	188505000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13771000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12367000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40416000	usd
CY2023Q3	us-gaap	Revenues Revenues	80106000	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	44663000	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	43308000	usd
CY2023Q3	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	10045000	usd
	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	31494000	usd
CY2024Q3	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	240000	usd
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	443000	usd
	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	8321000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	52012000	usd
	us-gaap	Operating Expenses OperatingExpenses	157694000	usd
	us-gaap	Operating Expenses OperatingExpenses	151357000	usd
CY2024Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	102000	usd
CY2023Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	737000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1718000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	13500000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	0	usd
CY2023Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	402000	usd
CY2024Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	202000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	202000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	28242000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	29033000	usd
	us-gaap	Profit Loss ProfitLoss	93852000	usd
	us-gaap	Profit Loss ProfitLoss	102662000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-298000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-313000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-891000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-946000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	28540000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	29346000	usd
	us-gaap	Net Income Loss NetIncomeLoss	94743000	usd
	us-gaap	Net Income Loss NetIncomeLoss	103608000	usd
CY2024Q3	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	29000	usd
CY2023Q3	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	19000	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	90000	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	38000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	28511000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	29327000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	94653000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	103570000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43476067	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388841	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43420663	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388779	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43987072	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43388841	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43658425	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43389675	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.39
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.65
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.68
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.17
	us-gaap	Profit Loss ProfitLoss	93852000	usd
	us-gaap	Profit Loss ProfitLoss	102662000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	199386000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	193720000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	182170000	usd
	us-gaap	Depreciation Depreciation	52763000	usd
	us-gaap	Depreciation Depreciation	52862000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4522000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3392000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	17000	usd
	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	323000	usd
	nhi	Amortization Of Lease Inducements AmortizationOfLeaseInducements	2168000	usd
	nhi	Amortization Of Lease Inducements AmortizationOfLeaseInducements	1798000	usd
	us-gaap	Straight Line Rent StraightLineRent	2066000	usd
	us-gaap	Straight Line Rent StraightLineRent	6011000	usd
	nhi	Noncash Rental Income NoncashRentalIncome	0	usd
	nhi	Noncash Rental Income NoncashRentalIncome	2500000	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	39000	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	1302000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1718000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	13500000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	402000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000	usd
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	4550000	usd
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1727000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3512000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3740000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2494000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2426000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3483000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1317000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-953000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-262000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	150195000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	131247000	usd
	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	27816000	usd
	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	33104000	usd
	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	14692000	usd
	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	11231000	usd
	nhi	Proceeds From Mortgage Fees Received ProceedsFromMortgageFeesReceived	82000	usd
	nhi	Proceeds From Mortgage Fees Received ProceedsFromMortgageFeesReceived	0	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	9866000	usd
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	38081000	usd
	us-gaap	Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans	4658000	usd
	us-gaap	Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans	51542000	usd
	nhi	Payments To Renovate Real Estate PaymentsToRenovateRealEstate	9717000	usd
	nhi	Payments To Renovate Real Estate PaymentsToRenovateRealEstate	5475000	usd
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	3551000	usd
	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	2579000	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	402000	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	2500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31116000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13966000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	244000000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	283000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	170000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	120000000	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	0	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	200000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	75327000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	365304000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2747000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	782000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	821000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1004000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	117250000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	117169000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5819000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	70000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2922000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-125929000	usd
	nhi	Additions Through Settlement Of Mortgage Note AdditionsThroughSettlementOfMortgageNote	22184000	usd
	nhi	Additions Through Settlement Of Mortgage Note AdditionsThroughSettlementOfMortgageNote	14200000	usd
	us-gaap	Notes Issued1 NotesIssued1	699000	usd
	nhi	Change In Accounts Payable Renovations Of Existing Real Estate ChangeInAccountsPayableRenovationsOfExistingRealEstate	-1430000	usd
	nhi	Change In Accounts Payable Renovations Of Existing Real Estate ChangeInAccountsPayableRenovationsOfExistingRealEstate	80000	usd
	nhi	Change In Accounts Payable Related To Distributions To Noncontrolling Interests ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests	-6000	usd
	nhi	Change In Accounts Payable Related To Distributions To Noncontrolling Interests ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests	-61000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	344000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	nhi	Reclassification Of Prepaid Equity Issuance Costs To Capital In Excess Of Par Value ReclassificationOfPrepaidEquityIssuanceCostsToCapitalInExcessOfParValue	0	usd
	nhi	Reclassification Of Prepaid Equity Issuance Costs To Capital In Excess Of Par Value ReclassificationOfPrepaidEquityIssuanceCostsToCapitalInExcessOfParValue	275000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1264391000	usd
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	70000	usd
	nhi	Distributions Attributable To Redeemable Noncontrolling Interest DistributionsAttributableToRedeemableNoncontrollingInterest	9000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	508000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-478000	usd
	nhi	Net Income Loss Excluding Gain Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossExcludingGainLossAttributableToRedeemableNoncontrollingInterest	66088000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2842000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.80
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	78180000	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-10088000	usd
CY2024Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	299000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-244000	usd
CY2024Q3	nhi	Net Income Loss Excluding Gain Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossExcludingGainLossAttributableToRedeemableNoncontrollingInterest	28486000	usd
CY2024Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	5419000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	670000	usd
CY2024Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	39260000	usd
CY2024Q3	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-15820000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1238483000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1280081000	usd
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2000000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	563000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-575000	usd
	nhi	Net Income Loss Excluding Gain Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossExcludingGainLossAttributableToRedeemableNoncontrollingInterest	74205000	usd
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	275000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2874000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.80
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	78119000	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	122000	usd
CY2023Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	380000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-250000	usd
CY2023Q3	nhi	Net Income Loss Excluding Gain Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossExcludingGainLossAttributableToRedeemableNoncontrollingInterest	29283000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	866000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	39069000	usd
CY2023Q3	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-9300000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1270903000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q3	nhi	Number Of Real Estate Properties Classified As Held For Sale NumberOfRealEstatePropertiesClassifiedAsHeldForSale	2	property
CY2024Q3	nhi	Number Of Health Care Mortgages Related To Mortgage Notes Receivables NumberOfHealthCareMortgagesRelatedToMortgageNotesReceivables	9	mortgage
CY2024Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	252000000.0	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19400000	usd
CY2024Q3	nhi	Number Of Real Estate Partnerships NumberOfRealEstatePartnerships	2	realestatepartnership
CY2023Q4	nhi	Number Of Real Estate Partnerships NumberOfRealEstatePartnerships	2	realestatepartnership
CY2024Q3	nhi	Number Of Real Estate Partnerships NumberOfRealEstatePartnerships	2	realestatepartnership
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22347000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19291000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15550000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16579000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit risks primarily relate to cash and cash equivalents and investments in mortgage and other notes receivable. Cash and cash equivalents are primarily held in bank accounts and overnight investments. We maintain our bank deposit accounts with large financial institutions in amounts that may exceed federally insured limits. We have not experienced any losses in such accounts. Our mortgage and other notes receivable consist primarily of secured loans on facilities. </span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments, principally our investments in mortgage and other notes receivable, are subject to the possibility of loss of the carrying values as a result of the failure of other parties to perform according to their contractual obligations which may make the instruments less valuable. We obtain collateral in the form of mortgage liens and other protective rights for mortgage and other notes receivable and continually monitor these rights in order to reduce such possibilities of loss. We evaluate the need to provide for reserves for potential losses on our financial instruments based on management’s periodic review of our portfolio on an instrument-by-instrument basis.</span></div>
	us-gaap	Revenue Recognition Leases RevenueRecognitionLeases	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rental Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Our leases generally provide for rent escalators throughout the term of the lease. Base rental income is recognized using the straight-line method over the term of the lease to the extent that lease payments are considered collectable and the lease provides for specific contractual escalators. Under certain leases, we receive additional contingent rent, which is calculated on the increase in revenues of the tenant over a base year or base quarter. We recognize contingent rent annually or quarterly based on the actual revenues of the tenant once the target threshold has been achieved. Lease payments that depend on a factor directly related to future use of the property, such as an increase in annual revenues over a base year, are considered to be contingent rent and are excluded from the schedule of minimum lease payments.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company reviews its operating lease receivables for collectability on a regular basis, taking into consideration changes in factors such as the tenant’s payment history, the financial condition of the tenant, business conditions in which the tenant operates and economic conditions in the area where the property is located. In the event that collectability of substantially all lease payments with respect to any tenant is not probable, a direct write-off of the receivable is made as an adjustment to rental income and any future rental revenue is recognized only when the tenant makes a rental payment. Reference Note 3 for further discussion.</span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Resident Fees and Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Resident fee and services revenue associated with our SHOP activities is recognized as the related performance obligations are satisfied and includes resident room charges, community fees and other resident charges. </span></div><div style="text-align:justify;text-indent:13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Residency agreements are generally short-term (30 days to one year), and entitle the resident to certain room and care services for a monthly fee billed in advance. Revenue for certain related services is billed monthly in arrears. The Company has elected the lessor practical expedient within Accounting Standards Codification (“ASC”) 842, Leases, not to separate the lease and nonlease components within our resident agreements as the timing and pattern of transfer to the resident are the same. The Company has determined that the nonlease component is the predominant component within the contract and recognizes revenue under ASC 606, Revenue Recognition from Contracts with Customers.</span></div>
	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">from Mortgage and Other Notes Receivable </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income is recognized based on the interest rates and principal amounts outstanding on the notes receivable. We identify a mortgage note or other note receivable as non-performing based on various criteria including timeliness of required payments, compliance with other provisions under the related note agreement, and an evaluation of the borrower’s current financial condition for indicators that it is probable it cannot pay its contractual amounts. A non-performing loan is returned to accrual status at such time as the note becomes contractually current and management believes </span>all future principal and interest will be received according to the contractual terms of the note.
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2024Q3	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	2600000	usd
CY2023Q3	nhi	Nonportfolio Assets Original Cost NonportfolioAssetsOriginalCost	2600000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19400000	usd
	nhi	Operating Lease Lease Income Escrow Funds OperatingLeaseLeaseIncomeEscrowFunds	8321000	usd
	nhi	Operating Lease Lease Income Escrow Funds OperatingLeaseLeaseIncomeEscrowFunds	8738000	usd
CY2024Q3	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2478355000	usd
CY2024Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	251961000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40416000	usd
	nhi	Percentage Of Continuing Revenue PercentageOfContinuingRevenue	0.16
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35860000	usd
	nhi	Percentage Of Continuing Revenue PercentageOfContinuingRevenue	0.15
	us-gaap	Revenues Revenues	249426000	usd
	us-gaap	Revenues Revenues	240370000	usd
CY2024Q3	nhi	Number Of Board Of Directors Members Also Members Of Nhc Board Of Directors NumberOfBoardOfDirectorsMembersAlsoMembersOfNHCBoardOfDirectors	2	boardmember
CY2024Q3	nhi	Lessor Net Book Value Of Leased Properties LessorNetBookValueOfLeasedProperties	5000000.0	usd
CY2024Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	400000	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	2500000	usd
CY2024Q2	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	300000	usd
CY2023Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	1500000	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	4300000	usd
CY2024Q3	nhi	Lessor Number Of Non Performing Notes Receivable LessorNumberOfNonPerformingNotesReceivable	2	loan
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	59197000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	239285000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	246076000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	199386000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	193720000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	182170000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	712948000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1832782000	usd
CY2024Q3	us-gaap	Lease Income LeaseIncome	63318000	usd
CY2023Q3	us-gaap	Lease Income LeaseIncome	62255000	usd
	us-gaap	Lease Income LeaseIncome	191265000	usd
	us-gaap	Lease Income LeaseIncome	188505000	usd
CY2024Q3	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	17	property
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19400000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	3600000	usd
CY2024Q3	nhi	Loans And Lease Receivable Number Of Underlying Properties LoansAndLeaseReceivableNumberOfUnderlyingProperties	2	property
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19411000	usd
CY2024Q3	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	232550000	usd
CY2024Q3	nhi	Probability Of Default Increase Current Conditions Adjustment ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment	0.20
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	712948000	usd
CY2024Q3	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	1832782000	usd
CY2024Q3	us-gaap	Lease Income LeaseIncome	63318000	usd
CY2023Q3	us-gaap	Lease Income LeaseIncome	62255000	usd
	us-gaap	Lease Income LeaseIncome	191265000	usd
	us-gaap	Lease Income LeaseIncome	188505000	usd
CY2024Q3	nhi	Number Of Health Care Properties Related To Mortgage Notes Receivables NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables	17	property
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19400000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Losses Period Increase Decrease FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease	3600000	usd
CY2024Q3	nhi	Loans And Lease Receivable Number Of Underlying Properties LoansAndLeaseReceivableNumberOfUnderlyingProperties	2	property
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19411000	usd
CY2024Q3	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	232550000	usd
CY2024Q3	nhi	Probability Of Default Increase Current Conditions Adjustment ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment	0.20
CY2024Q3	nhi	Probability Of Default Increase Current Conditions Adjustment ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment	0.20
CY2024Q3	nhi	Estimated Credit Losses Current Conditions Adjustment Combined EstimatedCreditLossesCurrentConditionsAdjustmentCombined	0.44
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15476000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19411000	usd
CY2024Q2	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	100000	usd
CY2024Q3	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	5000000.0	usd
CY2024Q3	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	-900000	usd
	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	-2100000	usd
CY2024Q3	nhi	Probability Of Default Increase Current Conditions Adjustment ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment	0.20
CY2024Q3	nhi	Estimated Credit Losses Current Conditions Adjustment Combined EstimatedCreditLossesCurrentConditionsAdjustmentCombined	0.44
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	15476000	usd
	us-gaap	Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal	3935000	usd
CY2024Q3	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	19411000	usd
CY2024Q2	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	100000	usd
CY2024Q3	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	5000000.0	usd
CY2024Q3	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	-900000	usd
	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	-2100000	usd
CY2023Q3	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	-600000	usd
	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	-1900000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
	nhi	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	2	extensionoption
CY2024Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2024Q3	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	11100000	usd
CY2024Q3	us-gaap	Incentive To Lessee IncentiveToLessee	8501000	usd
CY2023Q4	us-gaap	Incentive To Lessee IncentiveToLessee	10669000	usd
CY2023Q3	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	-600000	usd
	nhi	Equity Method Investment Unrealized Gain Loss On Disposal EquityMethodInvestmentUnrealizedGainLossOnDisposal	-1900000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P7Y
	nhi	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	2	extensionoption
CY2024Q3	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2024Q3	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	11100000	usd
CY2024Q3	us-gaap	Incentive To Lessee IncentiveToLessee	8501000	usd
CY2023Q4	us-gaap	Incentive To Lessee IncentiveToLessee	10669000	usd
CY2024Q3	us-gaap	Escrow Deposit EscrowDeposit	6208000	usd
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit	6208000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	2217000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	2270000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	245000000	usd
CY2024Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	6586000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8912000	usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1136302000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	325500000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	319000000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	100000000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	0	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	0	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	400000000	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1144925000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2037000	usd
CY2024Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	6586000	usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1136302000	usd
	nhi	Debt Leverage Limit Coupon Change Trigger DebtLeverageLimitCouponChangeTrigger	0.50
CY2024Q3	us-gaap	Escrow Deposit EscrowDeposit	6208000	usd
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit	6208000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	2217000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	2270000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	23163000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	24063000	usd
CY2024Q3	us-gaap	Line Of Credit LineOfCredit	319000000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	245000000	usd
CY2024Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	6586000	usd
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8912000	usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1136302000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1135051000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	425000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	325500000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	319000000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	100000000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	0	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	0	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	400000000	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1144925000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2037000	usd
CY2024Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	6586000	usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1136302000	usd
	nhi	Debt Leverage Limit Coupon Change Trigger DebtLeverageLimitCouponChangeTrigger	0.50
CY2024Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	14131000	usd
CY2023Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	14387000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	42247000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	41439000	usd
CY2024Q3	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	65000	usd
CY2023Q3	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	21000	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	152000	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	61000	usd
CY2024Q3	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	873000	usd
CY2023Q3	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	720000	usd
	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	2568000	usd
	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	1930000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	14939000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	15086000	usd
	us-gaap	Interest Expense InterestExpense	44663000	usd
	us-gaap	Interest Expense InterestExpense	43308000	usd
	us-gaap	Loans And Leases Receivable Commitments Fixed Rates LoansAndLeasesReceivableCommitmentsFixedRates	138200000	usd
CY2024Q3	nhi	Maximum Commitment For All Active Development Projects MaximumCommitmentForAllActiveDevelopmentProjects	33500000	usd
CY2024Q3	us-gaap	Development In Process DevelopmentInProcess	18400000	usd
CY2024Q3	nhi	Contingent Funding Commitment Amount Funded ContingentFundingCommitmentAmountFunded	1000000.0	usd
CY2024Q3	nhi	Contingent Funding Commitment ContingentFundingCommitment	6900000	usd
	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	-39000	usd
CY2024Q3	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	240000	usd
CY2024Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	14131000	usd
CY2023Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	14387000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	42247000	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	41439000	usd
CY2024Q3	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	65000	usd
CY2023Q3	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	21000	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	152000	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	61000	usd
CY2024Q3	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	873000	usd
CY2023Q3	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	720000	usd
	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	2568000	usd
	nhi	Amortization Of Financing Costs Exclusive Of Amounts Written Off AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff	1930000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	14939000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	15086000	usd
	us-gaap	Interest Expense InterestExpense	44663000	usd
	us-gaap	Loans And Leases Receivable Commitments Fixed Rates LoansAndLeasesReceivableCommitmentsFixedRates	138200000	usd
CY2024Q3	nhi	Maximum Commitment For All Active Development Projects MaximumCommitmentForAllActiveDevelopmentProjects	33500000	usd
CY2024Q3	us-gaap	Development In Process DevelopmentInProcess	18400000	usd
CY2024Q3	nhi	Contingent Funding Commitment Amount Funded ContingentFundingCommitmentAmountFunded	1000000.0	usd
CY2024Q3	nhi	Contingent Funding Commitment ContingentFundingCommitment	6900000	usd
	us-gaap	Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal	-39000	usd
CY2024Q3	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	240000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	9656000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-722000	usd
	nhi	Distributions Attributable To Redeemable Noncontrolling Interest DistributionsAttributableToRedeemableNoncontrollingInterest	9000	usd
CY2024Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	8925000	usd
CY2024Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	160000000.0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P1Y
CY2024Q3	nhi	Sale Of Stock Agreements To Sell SaleOfStockAgreementsToSell	2760000	shares
CY2024Q3	nhi	Sale Of Stock Exercise Price Available SaleOfStockExercisePriceAvailable	68.40
	nhi	Sale Of Stock Agreements To Sell SaleOfStockAgreementsToSell	2760000	shares
	nhi	Sale Of Stock Shares Available SaleOfStockSharesAvailable	187300000	shares
CY2024Q3	nhi	Sale Of Stock Exercise Price Available SaleOfStockExercisePriceAvailable	67.88
CY2024Q3	nhi	At The Market Shelf Registration Equity Offering Sales Agreement Aggregate Sales Price AtTheMarketShelfRegistrationEquityOfferingSalesAgreementAggregateSalesPrice	500000000.0	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2023Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
CY2024Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
CY2024Q3	nhi	Share Based Payment Arrangement Number Of Incentive Plans ShareBasedPaymentArrangementNumberOfIncentivePlans	2	plan
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.56
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.064
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.069
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.261
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.390
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0449
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0456
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	9656000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-722000	usd
	nhi	Distributions Attributable To Redeemable Noncontrolling Interest DistributionsAttributableToRedeemableNoncontrollingInterest	9000	usd
CY2024Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	8925000	usd
CY2024Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	160000000.0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P1Y
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2024Q3	nhi	Sale Of Stock Agreements To Sell SaleOfStockAgreementsToSell	2760000	shares
CY2024Q3	nhi	Sale Of Stock Exercise Price Available SaleOfStockExercisePriceAvailable	68.40
	nhi	Sale Of Stock Agreements To Sell SaleOfStockAgreementsToSell	2760000	shares
	nhi	Sale Of Stock Shares Available SaleOfStockSharesAvailable	187300000	shares
CY2024Q3	nhi	At The Market Shelf Registration Equity Offering Sales Agreement Aggregate Sales Price AtTheMarketShelfRegistrationEquityOfferingSalesAgreementAggregateSalesPrice	500000000.0	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.90
CY2024Q3	nhi	Share Based Payment Arrangement Number Of Incentive Plans ShareBasedPaymentArrangementNumberOfIncentivePlans	2	plan
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.56
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.069
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.261
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.390
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y10M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0449
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0456
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2216175	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	70.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	385500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	54.73
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5166	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	53.41
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	66.44
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2447171	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	68.80
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2078827	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	71.40
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2447171	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	68.80
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1065119	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	58.24
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	301837	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	79.96
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1511215	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	70.87
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y7D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y5M1D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23400000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	866000	usd
	us-gaap	Profit Loss ProfitLoss	102662000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-298000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-313000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-891000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-946000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	28511000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	29327000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	94653000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2216175	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	70.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	385500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	54.73
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5166	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	53.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	61168	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	66.44
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2447171	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	68.80
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2078827	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	71.40
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2447171	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	58.24
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	301837	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	79.96
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1511215	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	70.87
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y7D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1170521	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	74.94
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y5M1D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23400000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	14100000	usd
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	670000	usd
	us-gaap	Profit Loss ProfitLoss	93852000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	28540000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	29346000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	28511000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	29327000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	94653000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	94653000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	103570000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	103570000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43476067	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388841	shares
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	94653000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	103570000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	103570000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43476067	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388841	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43420663	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388779	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43476067	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43388841	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43420663	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43388779	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	346997	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	183093	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	896	shares
	us-gaap	Incremental Common Shares Attributable To Equity Forward Agreements IncrementalCommonSharesAttributableToEquityForwardAgreements	54669	shares
	us-gaap	Incremental Common Shares Attributable To Equity Forward Agreements IncrementalCommonSharesAttributableToEquityForwardAgreements	0	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43987072	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43388841	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43658425	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.39
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.65
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.68
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.39
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	86542	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	280157	shares
CY2024Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.70
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.70
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	operatingsegment
CY2024Q3	us-gaap	Lease Income LeaseIncome	63318000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13771000	usd
CY2024Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5855000	usd
CY2024Q3	us-gaap	Revenues Revenues	82944000	usd
CY2024Q3	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	10744000	usd
CY2024Q3	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	2786000	usd
CY2024Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	69414000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	17768000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43420663	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43388779	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43476067	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43388841	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43420663	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	43388779	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	346997	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	896	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Equity Forward Agreements IncrementalCommonSharesAttributableToEquityForwardAgreements	164008	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Equity Forward Agreements IncrementalCommonSharesAttributableToEquityForwardAgreements	0	shares
	us-gaap	Incremental Common Shares Attributable To Equity Forward Agreements IncrementalCommonSharesAttributableToEquityForwardAgreements	54669	shares
	us-gaap	Incremental Common Shares Attributable To Equity Forward Agreements IncrementalCommonSharesAttributableToEquityForwardAgreements	0	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43987072	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43388841	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43658425	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43389675	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.68
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.39
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.65
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.68
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.39
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	86542	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	816353	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	280157	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	781727	shares
CY2024Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.90
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.70
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.70
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	operatingsegment
CY2024Q3	us-gaap	Lease Income LeaseIncome	63318000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13771000	usd
CY2024Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5855000	usd
CY2024Q3	us-gaap	Revenues Revenues	82944000	usd
CY2024Q3	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	10744000	usd
CY2024Q3	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	2786000	usd
CY2024Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	69414000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	17768000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	14939000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	14939000	usd
CY2024Q3	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	240000	usd
CY2024Q3	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	83000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4810000	usd
CY2024Q3	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	3434000	usd
CY2024Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	102000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	28242000	usd
CY2024Q3	us-gaap	Assets Assets	2460090000	usd
CY2023Q3	us-gaap	Lease Income LeaseIncome	62255000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12367000	usd
CY2023Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5484000	usd
CY2023Q3	us-gaap	Revenues Revenues	80106000	usd
CY2023Q3	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	10045000	usd
CY2023Q3	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	2908000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	67153000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	17515000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	15086000	usd
CY2023Q3	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	67000	usd
CY2023Q3	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	2000	usd
CY2023Q3	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1959000	usd
CY2023Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	737000	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	202000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	29033000	usd
CY2023Q3	us-gaap	Assets Assets	2499090000	usd
	us-gaap	Lease Income LeaseIncome	191265000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40416000	usd
	us-gaap	Revenues Revenues	249426000	usd
	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	31494000	usd
	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	8321000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	209611000	usd
	us-gaap	Depreciation Depreciation	52763000	usd
	us-gaap	Interest Expense InterestExpense	44663000	usd
	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	641000	usd
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	-56000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15318000	usd
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	4550000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1718000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	402000	usd
	us-gaap	Profit Loss ProfitLoss	93852000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35860000	usd
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	16005000	usd
	us-gaap	Revenues Revenues	240370000	usd
	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	29525000	usd
	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	8738000	usd
	us-gaap	Interest Expense InterestExpense	43308000	usd
	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	364000	usd
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	443000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14390000	usd
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1727000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	13500000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	20000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	202000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000	usd
	us-gaap	Profit Loss ProfitLoss	102662000	usd
CY2024Q3	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	240000	usd
CY2024Q3	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	83000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4810000	usd
CY2024Q3	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	3434000	usd
CY2024Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	102000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	28242000	usd
CY2024Q3	us-gaap	Assets Assets	2460090000	usd
CY2023Q3	us-gaap	Lease Income LeaseIncome	62255000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12367000	usd
CY2023Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	5484000	usd
CY2023Q3	us-gaap	Revenues Revenues	80106000	usd
CY2023Q3	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	10045000	usd
CY2023Q3	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	2908000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	67153000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	17515000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	15086000	usd
CY2023Q3	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	67000	usd
CY2023Q3	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	2000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4430000	usd
CY2023Q3	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1959000	usd
CY2023Q3	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	737000	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	202000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	29033000	usd
CY2023Q3	us-gaap	Assets Assets	2499090000	usd
	us-gaap	Lease Income LeaseIncome	191265000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40416000	usd
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	17745000	usd
	us-gaap	Revenues Revenues	249426000	usd
	nhi	Senior Housing Operating Expenses SeniorHousingOperatingExpenses	31494000	usd
	us-gaap	Real Estate Taxes And Insurance RealEstateTaxesAndInsurance	8321000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	209611000	usd
	us-gaap	Depreciation Depreciation	52763000	usd
	us-gaap	Interest Expense InterestExpense	44663000	usd
	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	641000	usd
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	-56000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15318000	usd
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	4550000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	1718000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	402000	usd
	us-gaap	Profit Loss ProfitLoss	93852000	usd
	us-gaap	Lease Income LeaseIncome	188505000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35860000	usd
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	16005000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	202107000	usd
	us-gaap	Depreciation Depreciation	52862000	usd
	us-gaap	Interest Expense InterestExpense	43308000	usd
	nhi	Litigation Settlement Expense Benefit LitigationSettlementExpenseBenefit	364000	usd
	nhi	Franchise Excise And Other Taxes FranchiseExciseAndOtherTaxes	443000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14390000	usd
	nhi	Loanand Lease Lossesand Recoveries Net LoanandLeaseLossesandRecoveriesNet	1727000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	13500000	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	202000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-73000	usd
CY2023Q4	nhi	Number Of Real Estate Partnerships NumberOfRealEstatePartnerships	2	realestatepartnership
CY2024Q3	nhi	Variable Interest Rate Entity Number Of Mezzanine Loans VariableInterestRateEntityNumberOfMezzanineLoans	2	loan
CY2024Q3	nhi	Number Of Real Estate Partnerships NumberOfRealEstatePartnerships	2	realestatepartnership
CY2023Q4	nhi	Number Of Real Estate Partnerships NumberOfRealEstatePartnerships	2	realestatepartnership
CY2024Q3	nhi	Variable Interest Rate Entity Number Of Mezzanine Loans VariableInterestRateEntityNumberOfMezzanineLoans	2	loan
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000877860-24-000080-index-headers.html	Edgar Link	pending
0000877860-24-000080-index.html	Edgar Link	pending
0000877860-24-000080.txt	Edgar Link	pending
0000877860-24-000080-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nhi-20240930.htm	Edgar Link	pending
nhi-20240930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nhi-9302024x10qex311.htm	Edgar Link	pending
nhi-9302024x10qex312.htm	Edgar Link	pending
nhi-9302024x10qex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
nhi-20240930_def.xml	Edgar Link	unprocessable
nhi-20240930_lab.xml	Edgar Link	unprocessable
nhi-20240930_pre.xml	Edgar Link	unprocessable
nhi-20240930_htm.xml	Edgar Link	completed
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nhi-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi

2024 Q4 Form 10-Q Financial Statement

#000087786024000080 Filed on November 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI NATIONAL HEALTH INVESTORS INC Stock $nhi

2024 Q4 Form 10-Q Financial Statement

#000087786024000080 Filed on November 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHI
NATIONAL HEALTH INVESTORS INC Stock $nhi